ArticlePloS one2012

SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation.

Joshua D Mezrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.